Header Logo

Connection

CHRIS AMOS to Pharmacogenomic Variants

Back to Details
This is a "connection" page, showing publications CHRIS AMOS has written about Pharmacogenomic Variants.
CHRIS AMOS
Connection Strength
0.166
Pharmacogenomic Variants
  1. Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial. Clin Pharmacol Ther. 2020 12; 108(6):1315-1325.
    View in: PubMed
    Score: 0.166
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.